Healthy volunteers test new diabetes drug formulation
NCT ID NCT07056517
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study looked at how healthy adults process a drug called lobeglitazone, given as two different tablet types (a standard tablet and a melt-in-the-mouth tablet). Twenty-one participants took single doses under fasting and fed conditions to measure drug levels and safety. The goal was to gather basic information, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lobeglitazone
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain Metabolism Study Using PET/fMRI (NCT05756335)
- Short-term arm immobilization & muscle metabolis NCT06750497
- Parent-led app boosts kids' motor & brain skills NCT07680075
- DigiKids App-Based Motor Skills Trial for Kids (NCT07679633)
- QX-4533 Safety Study in Healthy People | NCT07678463
- Pomegranate Supplement & Gut Health in Alcohol L NCT07678567
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nucleus Network Pty Ltd.
Melbourne, Victoria, 3004, Australia